S/N 81449 service contract -facsca N 5 day, customer material no: 000500010
Ended Awarded Last action
- Contract number
- HHSN261FQ600977
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,304
Award facts
- Contract value 100% obligated
- $11,304.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Becton, Dickinson and Company (BD), through its BD Biosciences division, was awarded a delivery order contract by a federal agency valued at $11,304.24 with an ultimate completion date of September 30, 2006. This service contract, designated S/N 81449, was issued without a small business set-aside and represents a child contract order, indicating it was issued under a larger blanket purchase agreement or indefinite delivery vehicle. The contract was awarded on October 4, 2005, with performance to be completed in Bethesda, Maryland. As a global medical technology manufacturer, BD Biosciences specializes in sophisticated scientific instruments and reagents, particularly flow cytometry systems, cell imaging technologies, and associated laboratory equipment that support critical research and clinical applications across federal healthcare and research institutions.
BD maintains an established federal contracting presence across multiple agencies, including the Department of Veterans Affairs, National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Defense. The company's federal contract portfolio demonstrates consistent capacity to provide specialized flow cytometry instruments such as FACSymphony and LSRFortessa systems, maintenance services, and related consumables. This delivery order award reflects BD's competitive positioning in the federal marketplace and aligns with the company's core business focus on providing advanced biomedical research technologies to government healthcare and research facilities. The contract was competed on a full and open basis, consistent with BD's typical federal procurement profile as an established, large-scale medical device manufacturer.
Quick answers
Who was awarded contract HHSN261FQ600977?
HHSN261FQ600977 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on October 4, 2005.
How much is contract HHSN261FQ600977 worth?
The government has obligated $11,304 on HHSN261FQ600977.
Is contract HHSN261FQ600977 an order under another contract?
Yes. HHSN261FQ600977 is a delivery order under GS24F2044D, a federal supply schedule.
Was contract HHSN261FQ600977 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award